Oculis Holding AG (OCS) - Dilution Analysis

Visualizing historical and potential share dilution over time

Dilution Analysis

Medium Risk
Moderate dilution risk
Last updated: December 05, 2025

Risk Assessment Details

Potential Dilution: 10.98% of current shares
Recent Dilution: 24.55% (2 years)
Historical Dilution Factor: moderate recent dilution
Outstanding Shares
52M
Potential Supply
5.7M
Additional shares possible
Splits
None
Past 2 years

Summary

OCS currently has 52.4M outstanding shares. with limited dilution risk as only 5.75M additional shares (11.0%) are authorized for issuance. The company has diluted shareholders by 24.55% over the past 2 years through share issuances.

Share Structure Timeline

Outstanding Shares
Total Supply

Historical Data Points

Date Event Outstanding Supply
Dec 05, 2025

POS AM filing: This post-effective amendment is being filed to deregister all of the unsold securities previously registered under the Registration Statement.

52M 5.7M
Nov 10, 2025

F-3 filing: This F-3 filing registers the resale of up to 494,259 ordinary shares of Oculis Holding AG by a selling securityholder upon exercise of a warrant.

52M 6.1M
Mar 11, 2025

20-F filing | 43.7M shares outstanding

44M 14M
Aug 27, 2024

F-3 filing: Resale by the selling securityholder of up to 361,011 ordinary shares of Oculis Holding AG issuable upon the exercise of a warrant.

42M 16M
Apr 01, 2024

F-3 filing: Oculis Holding AG files an F-3 form to register a shelf offering of ordinary shares, senior debt securities, subordinated debt securities, warrants and units with an aggregate offering price not to exceed $300,000,000.

37M 21M
Apr 01, 2024

POS AM filing: This POS AM filing relates to the offer and sale of Ordinary Shares by Selling Securityholders. It includes information about indemnification of board members and executive committee, exhibits, and expenses related to the offering.

37M 21M
Mar 19, 2024

20-F filing | 36.6M shares outstanding

37M 32M
May 30, 2023

F-1 filing: The filing relates to an F-1 form filed on 2023-05-30, concerning the sale of ordinary shares. It discusses the redemption of warrants when ordinary shares trade at or above $10.00, below the exercise price of $11.50. It includes a table of expenses related to the offering, totaling $1,423,454.

33M 36M
Apr 03, 2023

F-1 filing: Oculis Holding AG is registering the issuance of up to 4,403,294 Ordinary Shares that may be issued upon exercise of Warrants, and the resale by the Selling Securityholders of up to 31,066,909 Ordinary Shares, and the resale by the Sponsor of up to 151,699 Private Placement Warrants to purchase Ordinary Shares.

33M 36M
Mar 28, 2023

20-F filing | 32.7M shares outstanding

33M 0
Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime